222. Primary nephrotic syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 382 / Drugs : 278 - (DrugBank : 98) / Drug target genes : 73 - Drug target pathways : 197
| Other names | - | ||
|---|---|---|---|
| Disease group | Kidney and urinary diseases | ||
|
Domestic patients
Med expenses recipients (FY2023) |
13,694 patients Age distribution
 💬 |
||
| Related info (in Japanese) | - | ||
| Clinical research form [April 1, 2025 ~] (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 2-1-1. Congenital nephrotic syndrome of the Finnish type; CNF | ||
| 2-1-2. Diffuse mesangial sclerosis; DMS | |||
| 2-1-7. Other nephrotic syndromes | |||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 222-1. | Minimal change nephrotic syndrome;MCNS; | 2-1-3. Minimal change nephrotic syndrome; MCNS | |
| 222-2. | Membranous nephropathy; | 2-1-5. Membranous nephropathy | |
| 222-3. | Focal segmental glomerulosclerosis;FSGS; | 2-1-4. Focal segmental glomerulosclerosis; FSGS | |
| 222-4. | Membranoproliferative glomerulonephritis;MPGN; | 2-2-10. Membranoproliferative glomerulonephritis; MPGN | |